Hypofrontality (a state of decreased cerebral blood flow in the prefrontal cortex of the brain) has been associated with a number of psychiatric diseases. In this episode, Micah raises the question of what’s behind this symptomatic response and asks if it could be the brain’s way of compensating for certain sensory deficits…
Sean takes time to recount the story of Cindy Black, an early enrolee in multi-gene testing for molecular matching. After many years of living with debilitating depression, Cindy went for broke, took the test and changed her life…
One of the key considerations of rTMS therapy is the individual treatment duration and the overall period of treatment required to effectively alleviate symptoms. In this video it’s time for some timely advice…
You want to know how being labelled as “mentally ill” can in and of itself destroy a life? Listen to Renaud as he so eloquently elucidates the semantic pitfalls and complex layers of guilt, stigma and hopelessness associated with coming to terms with a diagnosis…
Are PLEX particularly vulnerable to sensory and emotional overload and how do you find out? The discussion that follows Fernando’s question reveals PLEX insights into this convoluted topic and confirms them as valuable members of Micah’s research team…
Asked if psychogenetic profiling could alleviate the “rollercoaster” effect frequently associated with current medication regimes, Sean points out one of the universal truths hindering treatment using prescribed drugs – you gotta go the distance…
A brain scanner is a very serious piece of scientific kit with a massive price ticket beyond that of mere mortals – but, as the holidays approach, the SYNERGIES rTMS gang are hoping for something special in their stockings…
In a world where everyone starts off as “the norm”, when it comes to prescribing drugs, and then experiences the inevitable “suck it and see” effect, pharmacogenetics can identify more readily and accurately which direction to go in when looking for a more “effective” regime.
In an effort to clarify the mechanism behind rTMS and how much it relies on brain plasticity, Alynka identifies a dastardly dichotomy – how do you build the good connections without bringing the bad along with you…
Genetic “profiling” to optimise medication choice (Pharmacogenomics) has historically been priced out of the mainstream. Sean explains why this SYNERGIES programme could radically alter that situation…
